Location History:
- Goteborg, SE (1976)
- Goteborg C, SE (1977 - 1978)
Company Filing History:
Years Active: 1976-1978
Title: The Innovations of Bengt Arne Ablad
Introduction
Bengt Arne Ablad is a notable inventor based in Goteborg C, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new amines for cardiovascular treatment. With a total of 3 patents, Ablad's work has the potential to impact medical practices significantly.
Latest Patents
Ablad's latest patents include innovative compounds such as phenoxy propanolamines. These new amines are characterized by the formula ##STR1##, where the radicals R.sup.1, R.sup.2, and R.sup.3 can be various groups. These compounds are particularly useful in treating cardiovascular diseases by blocking cardiac and vascular beta-receptors. Another significant patent involves substituted ureido alkylene phenoxy propanolamines, which share a similar formula and application in cardiovascular treatment.
Career Highlights
Bengt Arne Ablad has been associated with Aktiebolaget Hassle, where he has contributed to groundbreaking research and development in the pharmaceutical industry. His work focuses on creating effective treatments for cardiovascular conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Ablad has collaborated with notable colleagues, including Peder Bernhard Berntsson and Arne Elof Brandstrom. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.
Conclusion
Bengt Arne Ablad's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cardiovascular treatments, demonstrating the importance of innovation in healthcare.